Literature DB >> 31949742

Expression of vimentin and Oct-4 in gallbladder adenocarcinoma and their relationship with vasculogenic mimicry and their clinical significance.

Yu Zhang1,2, Jing Xu1,2, Zhouyi Xu1,2, Yichao Wang1,2, Shiwu Wu1,2, Lu Wu1,2, Hong Song1,2, Lei Zhou2.   

Abstract

Vimentin (a marker of epithelial-mesenchymal transition), and Oct-4 (a marker of cancer stem cells) are predicative biomarkers for identifying malignant cell invasion and metastasis. Vasculogenic mimicry (VM), a newly discovered tumor characteristic that is common in highly invasive malignancies, is considered to be an important factor in evaluating the prognosis and metastasis of many malignancies. The following paper analyzes the correlation between vimentin, Oct-4, and VM in gallbladder adenocarcinoma (GBAC) specimens using immunohistochemistry in an attempt to elucidate the survival and clinicopathological parameters of changes in vimentin, Oct-4, and VM. Briefly, significantly higher positive expression rates of vimentin, Oct-4, and VM were observed in GBAC tissues than in the corresponding para-carcinoma tissues. In addition, the levels of vimentin, Oct-4, and VM were positively correlated with tumor grade, lymph node metastasis (LNM), infiltration of the surrounding tissues (STI), and tumor-node-metastasis (TNM) stage, as well as inversely with a patient's overall survival (OS) time. Moreover, the analysis of multiple factors shows that high vimentin, Oct-4, and VM levels, STI, and LNM as well as TNM stage were potential and significant factors for OS time in patients with GBAC. To sum up, the positive expression of vimentin, Oct-4, and VM may be undesirable factors for metastasis, invasion and prognosis, as well as effective therapeutic targets for GBAC. IJCEP
Copyright © 2018.

Entities:  

Keywords:  Gallbladder adenocarcinoma; Oct-4; VM; prognosis; vimentin

Year:  2018        PMID: 31949742      PMCID: PMC6962874     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  41 in total

Review 1.  Gallbladder cancer.

Authors:  Mislav Rakić; Leonardo Patrlj; Mario Kopljar; Robert Kliček; Marijan Kolovrat; Bozo Loncar; Zeljko Busic
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

Review 2.  Epithelial-mesenchymal transitions in tumour progression.

Authors:  Jean Paul Thiery
Journal:  Nat Rev Cancer       Date:  2002-06       Impact factor: 60.716

Review 3.  [The dual role of OCT4].

Authors:  Sonia Stefanovic; Michel Pucéat
Journal:  Med Sci (Paris)       Date:  2010-04       Impact factor: 0.818

4.  Identification of cancer stem cells in gallbladder carcinoma: a platform for the discovery of novel therapeutic targets.

Authors:  Xiaodong Wang
Journal:  Cancer Biol Ther       Date:  2010-12-01       Impact factor: 4.742

Review 5.  Vimentin as an integral regulator of cell adhesion and endothelial sprouting.

Authors:  Jui M Dave; Kayla J Bayless
Journal:  Microcirculation       Date:  2014-05       Impact factor: 2.628

Review 6.  Vasculogenic mimicry and tumor metastasis.

Authors:  Jingxin Zhang; Lili Qiao; Ning Liang; Jian Xie; Hui Luo; Guodong Deng; Jiandong Zhang
Journal:  J BUON       Date:  2016 May-Jun       Impact factor: 2.533

Review 7.  Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma.

Authors:  Mary J C Hendrix; Elisabeth A Seftor; Angela R Hess; Richard E B Seftor
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

Review 8.  Novel functions of vimentin in cell adhesion, migration, and signaling.

Authors:  Johanna Ivaska; Hanna-Mari Pallari; Jonna Nevo; John E Eriksson
Journal:  Exp Cell Res       Date:  2007-04-14       Impact factor: 3.905

9.  Molecular determinants of human uveal melanoma invasion and metastasis.

Authors:  Elisabeth A Seftor; Paul S Meltzer; Dawn A Kirschmann; Jacob Pe'er; Andrew J Maniotis; Jeffrey M Trent; Robert Folberg; Mary J C Hendrix
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

10.  Isoform switch of CD44 induces different chemotactic and tumorigenic ability in gallbladder cancer.

Authors:  Takeshi Miwa; Takuya Nagata; Hirofumi Kojima; Shinichi Sekine; Tomoyuki Okumura
Journal:  Int J Oncol       Date:  2017-07-03       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.